Skip to content

EMEUNEWS

Search
  • Congress Topics
    • Basic Research
    • Imaging
    • Metabolic and Crystal Arthropathies
    • Paediatric Rheumatology
    • Rare and Autoinflammatory Diseases
    • Rheumatoid Arthritis I – Clinical (non-therapeutic)
    • Rheumatoid arthritis II – therapeutic
    • Spondyloarthritis I – non-therapeutic
    • Spondyloarthritis II – therapeutic
  • Featured Content
  • Press Review
    • Annals of the Rheumatic Diseases
    • RMD Open
    • Arthritis and Rheumatology
    • Rheumatology (Oxford)
    • Arthritis Research and Therapy
    • Arthritis Care and Research
    • Seminars in Arthritis and Rheumatism
    • The Lancet Rheumatology
    • Miscellaneous
  • About EMEUNEWS
  • About EMEUNET
  • Contact Us
  • Subscribe here!

Tag: Osteoarthritis and osteoporosis

EULAR 2025 highlights…

EULAR 2025 Highlights – Osteoarthritis & Osteoporosis

18 Jul 2025
Phase I/II trial of Allocetra™ cell therapy for knee osteoarthritis: clinical evidence of response to modulation of inflammation Abstract format and assignment number: Poster POS0684  Presenting author: E. Galamidi (Israel) Date:…
EULAR 2024 Highlights…

EULAR 2024 Highlights – Osteoarthritis and Osteoporosis

21 Jul 202422 Jul 2024
Author: Dálifer Freites Núñez Wang et al. (OP0274) aimed to establish a pharmacodynamic model-based meta-analysis to quantitatively evaluate placebo response to intra-articular injections in OA clinical trials and to identify…

Seestrasse 240
CH 8802 Kilchberg (ZH)
Switzerland
emeunet@eular.ch
emeunet.eular.org

About EULAR
The European Alliance of Associations for Rheumatology, EULAR, is the organisation which represents the people with arthritis/rheumatism, health professionals in rheumatology (HPR) and scientific societies of rheumatology of all the European nations.
Visit website here

About EMEUNET
EMEUNET is an exciting community that started its activities in 2009, emanating from one of the objectives set by EULAR – "Bring on board high quality, young generation contributors in all EULAR activities".
Visit website here

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Spotify

Loading Comments...